Prostatic Neoplasms: all 6,484 studies
Page 37 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node DissectionCompletedNCT04185922Not applicable
- Cardiovascular Events in GnRH Agonist vs. AntagonistStatus unknownNCT04182594Phase 2
- Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After ProstatectomyActive, not recruitingNCT04181203Phase 3
- Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate.Status unknownNCT04180592Not applicable
- Acupuncture With Press Tack Needles for Perioperative Pain After Open Radical ProstatectomyCompletedNCT04172649Not applicable
- Transperineal Laser Ablation for Focal Treatment of Prostate CancerCompletedNCT04170478Not applicable
- How Does Prostate Cancer Metastasize? Studying the Role of Secreted Packages (Exosomes) From Fat Tissue in Lean and Obese PatientsStatus unknownNCT04167722
- Head- to Head Comparison of [68Ga]Ga-PSMA-11 With [18F]PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-StandardStatus unknownNCT04159090Not applicable
- 68Ga-THP-PSMA PET/CT in Prostate Cancer: Clinical Stage and RestageCompletedNCT04158817Early Phase 1
- Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate CancerStatus unknownNCT04154280Not applicable
- A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate CancerStatus unknownNCT04148885Phase 1/2
- A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate CancerActive, not recruitingNCT04147806Phase 1
- Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate CancerActive, not recruitingNCT04141709Not applicable
- Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCActive, not recruitingNCT04140526Phase 1/2
- Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.Status unknownNCT04139772Phase 3
- Phase II Trial of Focal Cryotherapy for Prostate CancerActive, not recruitingNCT04138914Not applicable
- Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the ProstateActive, not recruitingNCT04136353Phase 3
- Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialActive, not recruitingNCT04134260Phase 3
- The Role of Follicle Stimulating Hormone in Advanced Prostate CancerCompletedNCT04134130Not applicable
- 4Kscore Using Serum Stored UncentrifugedCompletedNCT04130776
- Precise Therapy for mCRPC Patients Through Whole Exome Sequencing(PTtWES)Status unknownNCT04126915
- Telomere Associated Variables (TAVs) in Prostate CancerCompletedNCT04124900
- Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer DetectionStatus unknownNCT04124107Not applicable
- A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are DescribedActive, not recruitingNCT04122976
- Whole Body Magnetic Resonance Imaging StudyStatus unknownNCT04117594
- Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.Status unknownNCT04116775Phase 2
- Safety and Targeting of Anti-hk2 Antibody in mCRPCTerminatedNCT04116164Early Phase 1
- Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early StageStatus unknownNCT04116086Not applicable
- Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate CancerActive, not recruitingNCT04114825Phase 2
- Microwave Needle Thermoablation for Treatment of Localized Prostate CancerCompletedNCT04113811Not applicable
- Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad)Status unknownNCT04110782
- Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve MenStatus unknownNCT04108871Not applicable
- A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPCStatus unknownNCT04108247Phase 1
- Effect of EHealth Coaching Program on Patient Reported Outcomes of Men With Prostate CancerCompletedNCT04106245Not applicable
- Evaluation of the Interest of Hyaluronic Acid in the Preservation of Sexual Function During Prostate CurietherapiesActive, not recruitingNCT04105920Not applicable
- A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 InactivationActive, not recruitingNCT04104893Phase 2
- The Prostate Liquid Study (PLiS)Status unknownNCT04102904
- F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical RecurrenceCompletedNCT04102553Phase 3
- A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPCTerminatedNCT04102124Phase 2
- Measurement of Circulating Tumor Cells in Prostate CancerStatus unknownNCT04101305
- Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ PlatformActive, not recruitingNCT04100811
- First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.Active, not recruitingNCT04097002Phase 1/2
- A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate CancerCompletedNCT04094519Phase 1
- New Biopsy Needle - Evaluation of Prostate Biopsy QualityCompletedNCT04091230Not applicable
- A Phase 2 Trial for Men With Metastatic Prostatic AdenocarcinomaCompletedNCT04090775Phase 2
- Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate CancerCompletedNCT04087980Not applicable
- A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate CancerCompletedNCT04087174Phase 1
- Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate CancerTerminatedNCT04085991Phase 2
- Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT StudyCompletedNCT04081779Not applicable
- Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and ComplicationsCompletedNCT04081636Not applicable
- Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRTActive, not recruitingNCT04081428
- First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate CancerTerminatedNCT04077021Phase 1
- Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal TherapyActive, not recruitingNCT04071236Phase 1/2
- Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)Active, not recruitingNCT04070209Phase 2
- Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerCompletedNCT04067960Early Phase 1
- Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate CancerActive, not recruitingNCT04067713
- Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate CancerActive, not recruitingNCT04067570Not applicable
- Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided BiopsyCompletedNCT04064047Not applicable
- ReIMAGINE Prostate Cancer ScreeningCompletedNCT04063566Not applicable
- Walking Football as a Supportive Medicine for Patients With Prostate CancerStatus unknownNCT04062162Not applicable
- ReIMAGINE Prostate Cancer RiskActive, not recruitingNCT04060589
- Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPCCompletedNCT04060394Phase 1/2
- Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate CancerCompletedNCT04060043Early Phase 1
- PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness TrainingCompletedNCT04057859
- Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomyCompletedNCT04053842Phase 2
- LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate CancerSuspendedNCT04053062Phase 1
- Exercise and Quality of Life During Androgen Deprivation TherapyStatus unknownNCT04050397Not applicable
- 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate CancerCompletedNCT04050215Phase 2
- Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone TherapyCompletedNCT04048252
- Accumulation of Dietary Bioactives and Prostate CancerCompletedNCT04046653Not applicable
- Focal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate CancerStatus unknownNCT04045756Not applicable
- Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0Active, not recruitingNCT04045717Phase 2
- Early Urinary Continence After Radical Prostatectomy: Surgical Procedure and Anatomic LandmarksCompletedNCT04043637
- An RCT to Compare Early Continence Recovery After RARP With or Without Sustainable Functional Urethral ReconstructionCompletedNCT04037800Not applicable
- Changes in Body Composition With Patients Under Androgen Deprivation TherapyStatus unknownNCT04037488
- Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong KongStatus unknownNCT04034953Not applicable
- A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in JapanCompletedNCT04034095
- Study of ORIC-101 in Combination With EnzalutamideTerminatedNCT04033328Phase 1
- Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate CancerStatus unknownNCT04031378Phase 2
- Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate CancerActive, not recruitingNCT04030338
- Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative TreatmentActive, not recruitingNCT04029714Not applicable
- Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients Undergoing ProstatectomyWithdrawnNCT04027270Not applicable
- MR/TRUS Fusion Guided Prostate BiopsyStatus unknownNCT04026763Not applicable
- INTREPId (INTermediate Risk Erection PreservatIon Trial)Active, not recruitingNCT04025372Phase 2
- Prostate Cancer BiobankActive, not recruitingNCT04024475
- Influence of EMT on CTCs and Disease Progression in Prostate CancerCompletedNCT04021394
- Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate CancerWithdrawnNCT04020094Phase 2
- European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-upCompletedNCT04017325
- Dynamic Whole Body Positron Emission Tomography/Computed Tomography ImagingStatus unknownNCT04017104
- A Registry for Hereditary Cancer Risk Assessment and Genetic TestingCompletedNCT04015102
- Robot-assisted vs Laparoscopic Radical Prostatectomy for Prostate Cancer TreatmentStatus unknownNCT04011865Not applicable
- Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET ScanningActive, not recruitingNCT04009967Phase 2
- Multi-modality Prostate Cancer Image Guided InterventionsCompletedNCT04009174Not applicable
- Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)CompletedNCT04009083Not applicable
- Acupuncture Pilot Study for Cancer-related Cognitive FunctionActive, not recruitingNCT04007770Phase 2
- Prostate Margin Reduction to Reduce Acute Rectal Toxicity (PROTRACT)Status unknownNCT04004858Not applicable
- 3TMPO (Triple-Tracer Strategy Against Metastatic Prostate CancerCompletedNCT04000776
- Comprehensive Lifestyle Improvement Program for Men With Prostate CancerCompletedNCT04000464Not applicable
- Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)Active, not recruitingNCT03999151Not applicable
- Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate LesionsActive, not recruitingNCT03998657Not applicable